Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

被引：0
|
作者：
Shuai Xia
Jasper Fuk-Woo Chan
Lijue Wang
Fanke Jiao
Kenn Ka-Heng Chik
Hin Chu
Qiaoshuai Lan
Wei Xu
Qian Wang
Chao Wang
Kwok-Yung Yuen
Lu Lu
Shibo Jiang
机构：
[1] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity
[2] The University of Hong Kong,State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine
[3] The University of Hong Kong-Shenzhen Hospital,Department of Clinical Microbiology and Infection Control
[4] Hong Kong Science and Technology Park,Centre for Virology, Vaccinology and Therapeutics
[5] Beijing Institute of Pharmacology and Toxicology,State Key Laboratory of Toxicology and Medical Countermeasures
来源：
Cell Research | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：404 / 406
页数：2
相关论文
共 50 条
  • [31] Audio Interview: The Omicron Variant of SARS-CoV-2
    Rubin, Eric J.
    Baden, Lindsey R.
    Karim, Salim S. Abdool
    Morrissey, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (23): : E96 - E96
  • [32] Omicron: A highly transmissible SARS-CoV-2 variant
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    GENE REPORTS, 2022, 27
  • [33] SARS-CoV-2 Omicron variant: Characteristics and prevention
    He, Xuemei
    Hong, Weiqi
    Pan, Xiangyu
    Lu, Guangwen
    Wei, Xiawei
    MEDCOMM, 2021, 2 (04): : 838 - 845
  • [34] Omicron: A SARS-CoV-2 variant of real concern
    Gattinger, Pia
    Tulaeva, Inna
    Borochova, Kristina
    Kratzer, Bernhard
    Trapin, Doris
    Kropfmuller, Anna
    Pickl, Winfried F.
    Valenta, Rudolf
    ALLERGY, 2022, 77 (05) : 1616 - 1620
  • [35] Recent insights into SARS-CoV-2 omicron variant
    da Silva, Severino Jefferson Ribeiro
    Kohl, Alain
    Pena, Lindomar
    Pardee, Keith
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [36] Why is the SARS-CoV-2 Omicron variant milder?
    Xia, Bingqing
    Wang, Yi
    Pan, Xiaoyan
    Cheng, Xi
    Ji, Hongying
    Zuo, Xiaoli
    Jiang, Hualiang
    Li, Jia
    Gao, Zhaobing
    INNOVATION, 2022, 3 (04):
  • [37] Plasma Neutralization of the SARS-CoV-2 Omicron Variant
    Schmidt, Fabian
    Muecksch, Frauke
    Weisblum, Yiska
    Da Silva, Justin
    Bednarski, Eva
    Cho, Alice
    Wang, Zijun
    Gaebler, Christian
    Caskey, Marina
    Nussenzweig, Michel C.
    Hatziioannou, Theodora
    Bieniasz, Paul D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06): : 599 - 601
  • [38] Determinants of reinfection with SARS-CoV-2 Omicron variant
    Bisharat, N.
    Campisi-Pinto, S.
    JOURNAL OF INFECTION, 2023, 87 (02) : 163 - 165
  • [39] Repurposing fusion inhibitor peptide against SARS-CoV-2
    Efaz, Faiyaz Md.
    Islam, Shafiqul
    Talukder, Shafi Ahmad
    Akter, Shaila
    Tashrif, Md. Zakaria
    Ali, Md. Ackas
    Sufian, Md. Abu
    Parves, Md. Rimon
    Islam, Md. Jahirul
    Halim, Mohammad A.
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2021, 42 (32) : 2283 - 2293
  • [40] A Novel Peptide-Based Detection of SARS-CoV-2 Antibodies
    Bulut, Aliye
    Temur, Betul Z.
    Kirimli, Ceyhun E.
    Gok, Ozgul
    Balcioglu, Bertan K.
    Ozturk, Hasan U.
    Uyar, Neval Y.
    Kanlidere, Zeynep
    Kocagoz, Tanil
    Can, Ozge
    BIOMIMETICS, 2023, 8 (01)
12345